Long-Term Safety of Canakinumab in Patients with Gouty Arthritis.

被引：0
|
作者：
So, Alexander [1 ]
Alten, Reike [2 ]
Schumacher, H. Ralph [3 ,4 ]
Bloch, Mark [5 ]
Bardin, Thomas [6 ]
John, Markus R. [7 ]
Krammer, Gerhard [7 ]
Nebesky, Jan Michael [7 ]
Tao, Aiyang [8 ]
Schlesinger, Naomi [9 ]
机构：
[1] Univ Lausanne, CHUV, Lausanne, Switzerland
[2] Charite, D-13353 Berlin, Germany
[3] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[4] VA Med Ctr, Philadelphia, PA USA
[5] Holdsworth House Med Practice, Sydney, NSW, Australia
[6] Hop Lariboisiere, F-75475 Paris, France
[7] Novartis Pharma AG, Basel, Switzerland
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] UMDNJ RWJMS, New Brunswick, NJ USA
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
144
引用
收藏
页码：S63 / S63
页数：1
相关论文
共 50 条
  • [31] Efficacy and Safety Of Canakinumab Pre-Filled Syringe Versus Triamcinolone Acetonide In Acute Gouty Arthritis Patients
    Sunkureddi, Prashanth
    Toth, Edith
    Brown, Jacques P.
    Moericke, Ruediger
    Nebesky, Jan Michael
    Krammer, Gerhard
    Tao, Aiyang
    John, Markus
    Kivitz, Alan
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S498 - S498
  • [32] Long-term efficacy of canakinumab in crFMF
    McHugh J.
    Nature Reviews Rheumatology, 2020, 16 (8) : 408 - 408
  • [33] Long-Term Golimumab Retention Rate in Patients with Psoriatic Arthritis. Is Concomitant DMARD Important?
    Serrano, Belen
    Gonzalez, Carlos M.
    Gonzalez, Roberto
    Gabriel Ovalles-Bonilla, Juan
    Carlos Nieto, Juan
    Martinez-Barrio, Julia
    Janta, Iustina
    Valor, Larissa
    Monteagudo, Indalecio
    Lopez Longo, Francisco Javier
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [34] Performance of Criteria for Remission in a Long-Term Observational Study of Patients with Early Rheumatoid Arthritis.
    Svensson, Bjorn
    Andersson, Maria L. E.
    Bala, Sidona-Valentina
    Forslind, Kristina
    Hafstrom, Ingiald
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S170 - S170
  • [35] LONG-TERM GOLIMUMAB RETENTION RATE IN PATIENTS WITH PSORIATIC ARTHRITIS. IS CONCOMITANT DMARD IMPORTANT?
    Serrano-Benavente, B.
    Gonzalez-Fernandez, C. M.
    Valor, L.
    Janta, I.
    Gonzalez-Benitez, R. D.
    Saenz Tenorio, C.
    Nieto-Gonzalez, J. C.
    Ovalles-Bonilla, J. G.
    Martinez-Barrio, J.
    Correyero Plaza, M.
    Garcia-Montoya, L.
    Lopez-Longo, F. J.
    Monteagudo Saez, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1580 - 1580
  • [36] Pharmacokinetics and pharmacodynamics of long-term tocilizumab therapy in patients with systemic juvenile idiopathic arthritis.
    De Benedetti, Fabrizio
    Brunner, Hermine
    Fettner, Scott
    Keane, Caroline
    Devlin, Clare
    Wang, Jianmei
    Ruperto, Nicolino
    PHARMACOTHERAPY, 2013, 33 (10): : E234 - E234
  • [37] Infliximab improves long-term quality of life and functional status in patients with rheumatoid arthritis.
    Kavanaugh, A
    Lipsky, P
    Furst, D
    Weisman, M
    St Clair, W
    Smolen, J
    Kalden, J
    Breedveld, F
    Patel, K
    Bala, M
    Maini, R
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S147 - S147
  • [38] Progressive improvement with long-term etanercept for refractory psoriatic arthritis.
    Prasad, R
    Schentag, CT
    Gladman, DD
    ARTHRITIS AND RHEUMATISM, 2004, 50 (12): : 4082 - 4083
  • [39] Long-term prognosis of work disability in early rheumatoid arthritis.
    Mau, W
    Braeuer, W
    Merkesdal, S
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S152 - S152
  • [40] ETHNIC SENSITIVITY ASSESSMENT OF CANAKINUMAB PHARMACOKINETICS AND PHARMACODYNAMICS IN GOUTY ARTHRITIS PATIENTS.
    Roberts, J.
    Tannenbaum, S.
    Sunkara, G.
    Chakraborty, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S127 - S127
12345